Does baseline strength influence adaptations to velocity loss threshold-based resistance training?

Authors

Junjie Tao, Tianyuan He, Xinjun Chen, Lin Xie, Jiaxin He, Kelin Huo

Published in

BMC sports science, medicine & rehabilitation. Volume 18. Issue 1. Sep 12, 2026. Epub Sep 12, 2026.

Abstract

This study examined whether baseline strength moderates the magnitude of adaptations to velocity loss (VL) threshold-based resistance training across different training populations.
A systematic search was conducted in PubMed, Web of Science, SPORTDiscus (EBSCO), and Embase up to January 2026. Randomized controlled trials were included if they implemented resistance training prescribed using predefined VL thresholds, lasted at least 3 weeks, reported quantifiable baseline strength data, and provided pre- and post-intervention measures of strength and/or power outcomes. Effect sizes were calculated as standardized within-group pre-post changes (Hedges' g). A three-level random-effects meta-regression model was applied to account for statistical dependence among multiple effect sizes within studies. Baseline strength (standardized 1RM) was examined as the primary moderator, with training status and VL threshold entered as additional moderators.
Sixteen studies providing 89 effect sizes were included. VL threshold-based resistance training produced a moderate overall within-group improvement in strength and power outcomes (g = 0.59, 95% CI [0.40, 0.77], p < 0.001). The omnibus test of moderators was not statistically significant (QM(4) = 1.09, p = 0.896). Baseline strength was not significantly associated with adaptation magnitude (β = -0.076, p = 0.355), and the interaction between baseline strength and training status was also not statistically significant (β = 0.045, p = 0.775).
VL threshold-based resistance training elicits moderate improvements in neuromuscular performance. Within the limitations of the available evidence, no statistically detectable moderation by baseline strength or categorical training status was observed. These findings suggest that current evidence does not clearly support modifying VL prescriptions solely on the basis of baseline strength; however, equivalence across populations cannot be definitively established.

PMID:
42827250
Bibliographic data and abstract were imported from PubMed on 03 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.